According to Okyo Pharma's latest financial reports the company has $4.04 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | $4.04 M | 49.79% |
2022-03-31 | $2.7 M | -71.48% |
2021-03-31 | $9.47 M | 3158.06% |
2020-03-31 | $0.29 M | -64.43% |
2019-03-31 | $0.81 M | -79.31% |
2018-03-31 | $3.95 M | -84.64% |
2017-03-31 | $25.71 M | 248.79% |
2016-03-31 | $7.37 M | -23% |
2015-03-31 | $9.57 M | -51.35% |
2014-03-31 | $19.68 M | -9.68% |
2013-03-31 | $21.78 M | -20.12% |
2012-03-31 | $27.27 M | 5.6% |
2011-03-31 | $25.83 M | -68.57% |
2010-03-31 | $82.18 M | 86.99% |
2009-03-31 | $43.94 M | 23.26% |
2008-03-31 | $35.65 M |